Zacks Research Issues Negative Estimate for Itron Earnings

Itron, Inc. (NASDAQ:ITRI) – Equities research analysts at Zacks Research decreased their Q1 2026 earnings per share estimates for shares of Itron in a note issued to investors on Tuesday, March 10th. Zacks Research analyst Team now expects that the scientific and technical instruments company will earn $1.26 per share for the quarter, down from their prior estimate of $1.41. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q2 2026 earnings at $1.44 EPS, Q3 2026 earnings at $1.55 EPS, Q4 2026 earnings at $1.73 EPS, FY2026 earnings at $5.98 EPS, Q2 2027 earnings at $1.71 EPS, FY2027 earnings at $6.72 EPS and FY2028 earnings at $8.86 EPS.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.19 by $0.27. Itron had a return on equity of 20.04% and a net margin of 12.72%.The firm had revenue of $571.66 million for the quarter, compared to the consensus estimate of $561.31 million. During the same period in the previous year, the business earned $1.35 earnings per share. The company’s revenue for the quarter was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS.

Other equities analysts have also recently issued reports about the stock. Guggenheim set a $155.00 price target on shares of Itron in a research note on Friday, February 13th. Weiss Ratings downgraded shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 target price on the stock in a research report on Monday, January 5th. Wall Street Zen cut shares of Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Finally, Needham & Company LLC began coverage on shares of Itron in a research report on Friday, March 6th. They set a “buy” rating and a $124.00 price target for the company. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $137.10.

Itron Price Performance

Itron stock opened at $91.96 on Wednesday. Itron has a one year low of $88.57 and a one year high of $142.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.56 and a current ratio of 1.80. The business has a fifty day moving average of $97.46 and a two-hundred day moving average of $107.18. The company has a market cap of $4.13 billion, a P/E ratio of 14.13, a price-to-earnings-growth ratio of 0.81 and a beta of 1.44.

Institutional Trading of Itron

Several institutional investors have recently made changes to their positions in the stock. Pacer Advisors Inc. acquired a new position in Itron during the fourth quarter valued at approximately $12,864,000. Mercer Global Advisors Inc. ADV raised its stake in shares of Itron by 18.8% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 2,787 shares of the scientific and technical instruments company’s stock valued at $259,000 after acquiring an additional 441 shares during the period. XTX Topco Ltd purchased a new position in shares of Itron in the 4th quarter valued at $1,032,000. Voloridge Investment Management LLC lifted its holdings in shares of Itron by 164.1% during the 4th quarter. Voloridge Investment Management LLC now owns 197,536 shares of the scientific and technical instruments company’s stock valued at $18,343,000 after acquiring an additional 122,733 shares in the last quarter. Finally, Symmetry Investments LP purchased a new stake in Itron during the 4th quarter worth $3,334,000. 96.19% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Itron

In related news, SVP Christopher E. Ware sold 763 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $100.17, for a total transaction of $76,429.71. Following the sale, the senior vice president owned 31,043 shares of the company’s stock, valued at $3,109,577.31. This trade represents a 2.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Donald L. Reeves III sold 519 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $97.84, for a total transaction of $50,778.96. Following the transaction, the senior vice president directly owned 29,951 shares in the company, valued at $2,930,405.84. The trade was a 1.70% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 51,180 shares of company stock valued at $5,085,475. 1.45% of the stock is owned by company insiders.

More Itron News

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Zacks raised its Q2 2027 EPS forecast to $1.71 from $1.66, suggesting improved expected momentum in 2027. MarketBeat: ITRI
• Positive Sentiment: Zacks materially increased its Q4 2026 estimate to $1.73 from $1.49, indicating stronger anticipated year‑end profitability. MarketBeat: ITRI
• Positive Sentiment: Zacks published a FY2028 EPS projection of $8.86, signaling upside expectations over the longer term. MarketBeat: ITRI
• Neutral Sentiment: Zacks kept a “Hold” rating on ITRI and left the consensus full‑year view near prior levels (the broader consensus remains ~ $5.33 FY). MarketBeat: ITRI
• Negative Sentiment: Zacks trimmed several near‑term estimates: Q1 2026 cut to $1.26 (from $1.41), Q2 2026 to $1.44 (from $1.51), Q3 2026 to $1.55 (from $1.60) and modestly reduced FY2026/FY2027 numbers — near‑term earnings downgrades can weigh on the share price. MarketBeat: ITRI
• Negative Sentiment: Short interest surged ~42.7% in February to ~4.88M shares (about 11% of the float) with a ~2.5 days‑to‑cover — this elevated shorting increases downside pressure and potential volatility.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.